Mezcla de enzimas Gateway™ BP Clonase™ II
Product Image
Invitrogen™

Mezcla de enzimas Gateway™ BP Clonase™ II

La mezcla de enzimas Gateway™ BP Clonase™ II cataliza la recombinación in vitro de productos de reacción en cadena deMás información
Have Questions?
Cambiar vistabuttonViewtableView
Número de catálogoCantidad
11789100100 reacciones
1178902020 reacciones
Número de catálogo 11789100
Precio (CLP)
1.704.435
Each
Añadir al carro de la compra
Cantidad:
100 reacciones
Precio (CLP)
1.704.435
Each
Añadir al carro de la compra
La mezcla de enzimas Gateway™ BP Clonase™ II cataliza la recombinación in vitro de productos de reacción en cadena de la polimerasa (PCR) y la subclonación de segmentos de ADN de clones (que contiene sitios attB) y un vector de donante (que contiene sitios attP) para generar clones de entrada. Gateway™ BP Clonase™ II contiene enzimas y un tampón en una sola mezcla para facilitar una práctica reacción de diez microlitros en menos pasos de pipeteo.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Tampón compatibleTampón de enzimas
Tipo de productoMezcla de enzimas BP Clonase
Cantidad100 reacciones
Condiciones de envíoHielo seco
EnzimaBP clonase
Línea de productosClonase, Gateway
Unit SizeEach
Contenido y almacenamiento
La mezcla de enzimas Gateway™ BP Clonase™ II incluye una solución de proteinasa K (2 µg/µl) y un vector de control positivo. Almacenar a - 20 °C o - 80 °C. Se garantiza la estabilidad durante 6 meses si se almacena correctamente.

Preguntas frecuentes

I performed a BP reaction and got high background after transformation. Can you please offer some troubleshooting tips?

– Check whether the reaction was transformed into an E.coli strain containing the F' episome and the ccdA gene – use an E.coli strain that does not contain the F' episome, e.g. DH10B, TOP10.
– Deletion (full or partial) of the ccdB gene – propagate in media with 50-100 mg/mL ampicillin and 15-30 µg/mL chloramphenicol.
– Contamination from another resistant strain.
– Check whether proper amount of DNA was used in the reaction.

I performed a BP reaction and got two distinct types of colonies (large and small) after transformation. How should I proceed?

Typically when both large and small colonies are produced following BP recombination, we recommend screening several of both of the small and large colony types by analytical restriction digest, PCR with gene specific primers, or by sequencing to determine what you have and decide on the best course forward. If one of the colonies you analyze contains your desired entry clone, then you may proceed with this entry clone to an LR reaction to produce your desired expression clone.

There are several possible causes of this issue:

– Plasmid was lost during culture due to large size or toxicity – To improve results next time you perform a BP reaction with a tricky insert, you may try incubating your transformation plate at 30 degrees C and/or use Stbl2 E.coli to stabilize the plasmid. We also recommend performing the BP reaction positive control pEXP7-Tet alongside your BP cloning reaction of interest; the results of that control reaction will let you know whether the large and small colony phenotype is specific to your insert of interest.

– Deletions (full or partial) or point mutations in the ccdB gene – A negative BP reaction control (with no BP clonase added) should not produce any colonies – If a no BP clonase negative control produces colonies, then the ccdB/chlorophenicol cassette is compromised and we recommend to obtain a new pDONR vector.br/>
– Background on antibiotic selection plate due to contamination or expired antibiotic – If you run a no plasmid added transformation negative control plate, then this plate should not produce any colonies. Colonies on transformation negative control plate suggests contamination or need to make fresh plates.

I performed a BP reaction and got no colonies after transformation, and the recombination positive control was not successful. Can you please offer some suggestions?

– Check the competent cells with pUC19 transformation.
– Increase the amount plated.

I performed a BP reaction and got few or no colonies after transformation, whereas the transformation control gave colonies. Can you please offer some suggestions?

– Increase the incubation time up to 18 hours.
– Make sure to treat reactions with proteinase K before transformation.
– Check whether the correct antibiotic was used for selection.
– Check whether the att site sequences are correct.
– Check whether the correct Clonase enzyme was used and whether it was functional.
– Check whether the recommended amount of DNA was used in the reaction.
– Check primer design and try gel/PEG purifying the attB-PCR product.
– If the attB-PCR product or linear attB Expression clone is too long (>5 kb), incubate the BP reaction overnight.

What is the difference between BP Clonase and BP Clonase II and between LR Clonase and LR Clonase II?

BP Clonase and LR Clonase have the 5X BP reaction buffer or the 5X LR reaction buffer, respectively, in separate vials and require storage at -80 degrees C. On the other hand, BP Clonase II and LR Clonase II offer the convenience of pre-mixed BP Clonase /LR Clonase and 5X BP/LR reaction buffer, respectively. These pre-mixed formulations are more stable at -20 degrees C.

Citations & References (4)

Citations & References
Abstract
The alliance for cellular signaling plasmid collection: a flexible resource for protein localization studies and signaling pathway analysis.
Authors:Zavzavadjian JR, Couture S, Park WS, Whalen J, Lyon S, Lee G, Fung E, Mi Q, Liu J, Wall E, Santat L, Dhandapani K, Kivork C, Driver A, Zhu X, Chang MS, Randhawa B, Gehrig E, Bryan H, Verghese M, Maer A, Saunders B, Ning Y, Subramaniam S, Meyer T, Simon MI, O'Rourke N, Chandy G, Fraser ID,
Journal:Mol Cell Proteomics
PubMed ID:17192258
'Cellular responses to inputs that vary both temporally and spatially are determined by complex relationships between the components of cell signaling networks. Analysis of these relationships requires access to a wide range of experimental reagents and techniques, including the ability to express the protein components of the model cells in ... More
Gateway RFP-fusion vectors for high throughput functional analysis of genes.
Authors:Park JY, Hwang EM, Park N, Kim E, Kim DG, Kang D, Han J, Choi WS, Ryu PD, Hong SG,
Journal:Mol Cells
PubMed ID:17646710
'There is an increasing demand for high throughput (HTP) methods for gene analysis on a genome-wide scale. However, the current repertoire of HTP detection methodologies allows only a limited range of cellular phenotypes to be studied. We have constructed two HTP-optimized expression vectors generated from the red fluorescent reporter protein ... More
Development of R4 gateway binary vectors (R4pGWB) enabling high-throughput promoter swapping for plant research.
Authors:Nakagawa T, Nakamura S, Tanaka K, Kawamukai M, Suzuki T, Nakamura K, Kimura T, Ishiguro S,
Journal:Biosci Biotechnol Biochem
PubMed ID:18256458
We developed a new series of Gateway binary vectors, R4pGWBs, that are plant transformation vectors designed for one-step construction of chimeric genes between any promoter and any cDNA. The structure of R4pGWBs is almost the same as the promoterless type of improved pGWBs (ImpGWBs), except that the attR1 site is ... More
The full-ORF clone resource of the German cDNA Consortium.
Authors:Bechtel S, Rosenfelder H, Duda A, Schmidt CP, Ernst U, Wellenreuther R, Mehrle A, Schuster C, Bahr A, Blöcker H, Heubner D, Hoerlein A, Michel G, Wedler H, Köhrer K, Ottenwälder B, Poustka A, Wiemann S, Schupp I,
Journal:BMC Genomics
PubMed ID:17974005
BACKGROUND: With the completion of the human genome sequence the functional analysis and characterization of the encoded proteins has become the next urging challenge in the post-genome era. The lack of comprehensive ORFeome resources has thus far hampered systematic applications by protein gain-of-function analysis. Gene and ORF coverage with full-length ... More